Home/Investors/8VC

8VC

Biotech Investor · 4 portfolio companies

Portfolio

4

Focus Areas

8

Top Stage

Pre-clinical

Investment Focus

Oncology Immunology Infectious Disease Central Nervous System (CNS)Ocular Genetic Disorders Autoimmune Diseases Inflammatory Diseases

Portfolio Companies

Company	Stage	Valuation	Focus
Alloy Therapeutics	platform	—	Oncology, Immunology
Latus Bio	Pre-clinical	—	Central Nervous System (CNS), Ocular
Latent Labs	Pre-clinical	—	—
Sonoma Biotherapeutics	Phase 1	—	Autoimmune Diseases, Inflammatory Diseases

Frequent Co-Investors

Frazier Life Sciences1 shared DCVC Bio1 shared ARCH Venture Partners1 shared Mubadala Capital1 shared Sofinnova Partners1 shared Alexandria Venture Investments1 shared Section 321 shared Bristol Myers Squibb1 shared